CS265248B2 - Process for preparing analogs of rebeccamycine - Google Patents

Process for preparing analogs of rebeccamycine Download PDF

Info

Publication number
CS265248B2
CS265248B2 CS878249A CS824987A CS265248B2 CS 265248 B2 CS265248 B2 CS 265248B2 CS 878249 A CS878249 A CS 878249A CS 824987 A CS824987 A CS 824987A CS 265248 B2 CS265248 B2 CS 265248B2
Authority
CS
Czechoslovakia
Prior art keywords
rebeccamycin
formula
derivative
hydrogen atom
radical
Prior art date
Application number
CS878249A
Other languages
Czech (cs)
English (en)
Other versions
CS824987A2 (en
Inventor
Takushi Kaneko
Henry S Wong
Jacob J Utzig
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CS824987A2 publication Critical patent/CS824987A2/cs
Publication of CS265248B2 publication Critical patent/CS265248B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
CS878249A 1986-11-21 1987-11-17 Process for preparing analogs of rebeccamycine CS265248B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/933,428 US4785085A (en) 1986-11-21 1986-11-21 Rebeccamycin analogs

Publications (2)

Publication Number Publication Date
CS824987A2 CS824987A2 (en) 1989-01-12
CS265248B2 true CS265248B2 (en) 1989-10-13

Family

ID=25463937

Family Applications (1)

Application Number Title Priority Date Filing Date
CS878249A CS265248B2 (en) 1986-11-21 1987-11-17 Process for preparing analogs of rebeccamycine

Country Status (28)

Country Link
US (1) US4785085A (de)
EP (1) EP0269025B1 (de)
JP (1) JPS63198695A (de)
KR (1) KR910000897B1 (de)
CN (1) CN1019806B (de)
AT (1) ATE84539T1 (de)
AU (1) AU614068B2 (de)
CA (1) CA1287349C (de)
CS (1) CS265248B2 (de)
CY (1) CY1701A (de)
DE (1) DE3783577T2 (de)
DK (1) DK165986C (de)
EG (1) EG18409A (de)
ES (1) ES2053510T3 (de)
FI (1) FI86189C (de)
GR (1) GR3006776T3 (de)
HK (1) HK49093A (de)
HU (1) HU201773B (de)
IE (1) IE60595B1 (de)
IL (1) IL84515A (de)
MX (1) MX9202849A (de)
MY (1) MY102722A (de)
NO (1) NO167741C (de)
NZ (1) NZ222544A (de)
PT (1) PT86188B (de)
SG (1) SG25193G (de)
YU (1) YU46087B (de)
ZA (1) ZA878714B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07113027B2 (ja) * 1987-12-24 1995-12-06 協和醗酵工業株式会社 Ｋ−２５２誘導体
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
DE3835842A1 (de) * 1988-10-21 1990-04-26 Goedecke Ag Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
US5015578A (en) * 1989-03-23 1991-05-14 Bristol-Myers Squibb Company BMY-41950 antitumor antibiotic
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5496809A (en) * 1989-05-10 1996-03-05 Bristol-Myers Squibb Co Stable solutions of rebeccamycin analog
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Rebeccamycin analogs, their production and pharmaceutical compositions containing them
JPH0725787B2 (ja) * 1990-03-06 1995-03-22 ブリストル−マイヤーズ スクイブ カンパニー 臭化物前駆物質物質供給によるレベカマイシン類似体
US5344823A (en) * 1990-03-06 1994-09-06 Bristol-Myers Squibb Company Antitumor antibiotic BMY-41219
US5158938A (en) * 1990-03-06 1992-10-27 Bristol-Myers Squibb Company Rebeccamycin
US5478813A (en) * 1990-05-11 1995-12-26 Banyu Pharmaceutical Co., Ltd. Antitumor substance BE-13793C derivatives
EP0528030B1 (de) * 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Be-13793c-derivat mit antitumorwirkung
US5589365A (en) * 1991-11-29 1996-12-31 Banyu Pharmaceutical Co., Ltd. Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
US5437996A (en) * 1992-11-24 1995-08-01 Banyu Pharmaceutical Co., Ltd. Microtetraspora strain for preparation of indolopyrrolocarbazole derivatives
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
US5591842A (en) * 1991-11-29 1997-01-07 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives
CA2130836A1 (en) * 1992-03-20 1993-09-30 Martin J. Slater Further indole derivatives with antiviral activity
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
PL182124B1 (pl) * 1993-12-07 2001-11-30 Lilly Co Eli Nowe zwiazki oraz srodek farmaceutyczny przeznaczony do leczenia powiklan cukrzycowych lub do leczenia nowotworów PL PL PL PL PL PL PL PL
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
EP0657411B1 (de) * 1993-12-07 1999-06-09 Eli Lilly And Company Synthese von Bisindolylmaleimiden
US5541347A (en) * 1993-12-07 1996-07-30 Eli Lilly And Company Synthesis of bisindolylmaleimides
US5545636A (en) * 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
DK0817627T3 (da) * 1993-12-23 2005-06-06 Lilly Co Eli Inhibitorer af proteinkinase C
US5922860A (en) * 1994-05-09 1999-07-13 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5804564A (en) * 1994-05-09 1998-09-08 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
WO1995030682A1 (en) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyprolocarbazole derivative
JP3707075B2 (ja) * 1994-06-13 2005-10-19 萬有製薬株式会社 グリコシルトランスフェラーゼをコードする遺伝子及びその用途
US5491242A (en) * 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) * 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
ES2123873T3 (es) * 1994-08-04 1999-01-16 Hoffmann La Roche Pirrolocarbazol.
AU6836696A (en) * 1995-09-05 1997-03-27 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
KR20000064764A (ko) * 1996-03-20 2000-11-06 피터지.스트링거 인돌릴말레이미드의제조방법
US5859261A (en) * 1997-03-20 1999-01-12 Eli Lilly And Company Synthesis of indolylmaleimides
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6653290B2 (en) * 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
JP2004534006A (ja) 2001-03-22 2004-11-11 ブリストル−マイヤーズ　スクイブ　カンパニー インドロピロロカルバゾール化合物のトポイソメラーゼｉ選択的細胞毒シュガー誘導体
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
EP1666485A1 (de) * 2003-09-16 2006-06-07 Banyu Pharmaceutical Co., Ltd. Neues indolopyrrolocarbazolderivat mit antitumorwirkung
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
EP2398500B1 (de) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Arzneiabgabesystem auf glutathion-basis
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102898489B (zh) * 2010-11-24 2014-04-02 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法
CN102125578B (zh) * 2010-11-24 2013-03-27 河南师范大学 具有抗癌活性的蝴蝶霉素类似物及合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487925A (en) * 1983-01-28 1984-12-11 Bristol-Myers Company Rebeccamycin and process for its preparation
US4552842A (en) * 1983-01-28 1985-11-12 Bristol-Myers Company Process for producing rebeccamycin
US4524145A (en) * 1984-09-04 1985-06-18 Bristol-Myers Company 4'-Deschlororebeccamycin pharmaceutical composition and method of use
JPS62220196A (ja) * 1986-03-20 1987-09-28 Kyowa Hakko Kogyo Co Ltd 新規物質ｕｃｎ―０１

Also Published As

Publication number Publication date
DK165986B (da) 1993-02-22
CS824987A2 (en) 1989-01-12
YU46087B (sh) 1992-12-21
CN1019806B (zh) 1992-12-30
CN87107928A (zh) 1988-08-10
AU614068B2 (en) 1991-08-22
JPS63198695A (ja) 1988-08-17
ES2053510T3 (es) 1994-08-01
ZA878714B (de) 1988-05-20
FI875091A7 (fi) 1988-05-22
FI86189C (fi) 1992-07-27
SG25193G (en) 1993-05-21
MX9202849A (es) 1992-06-30
CY1701A (en) 1994-01-14
EP0269025B1 (de) 1993-01-13
KR910000897B1 (ko) 1991-02-12
FI875091A0 (fi) 1987-11-18
US4785085A (en) 1988-11-15
JPH05400B2 (de) 1993-01-05
YU208687A (en) 1988-10-31
CA1287349C (en) 1991-08-06
DK612987D0 (da) 1987-11-20
DK165986C (da) 1993-07-19
IL84515A (en) 1991-11-21
AU8114887A (en) 1988-05-26
GR3006776T3 (de) 1993-06-30
ATE84539T1 (de) 1993-01-15
NO874857D0 (no) 1987-11-20
EP0269025A2 (de) 1988-06-01
EG18409A (en) 1993-02-28
NO874857L (no) 1988-05-24
IL84515A0 (en) 1988-04-29
NZ222544A (en) 1990-11-27
PT86188B (pt) 1990-11-07
NO167741C (no) 1991-12-04
DE3783577T2 (de) 1993-05-19
HU201773B (en) 1990-12-28
DK612987A (da) 1988-05-22
HK49093A (en) 1993-05-27
FI86189B (fi) 1992-04-15
IE873152L (en) 1988-05-21
KR880006246A (ko) 1988-07-22
DE3783577D1 (de) 1993-02-25
PT86188A (en) 1987-12-01
MY102722A (en) 1992-09-30
NO167741B (no) 1991-08-26
HUT45543A (en) 1988-07-28
EP0269025A3 (en) 1990-08-29
IE60595B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
EP0269025B1 (de) Rebeccamycin-analoge Verbindungen
US5070092A (en) Pyrroloindole derivatives related to dc-88a compound
US5187186A (en) Pyrroloindole derivatives
US4808613A (en) Rebeccamycin derivative containing pharmaceutical composition
US5977165A (en) Radicicol derivatives
US4268676A (en) Mitomycin analogs
JPH01308267A (ja) 新規なアリステロマイシン／アデノシン誘導体類
US5922860A (en) Antitumor indolopyrrolocarbazole derivatives
WO2003002563A1 (fr) Derives de pyrido-pyrido-pyrrolo pyrrolo-indole et pyrido-pyrrolo pyrrolo carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2801054A1 (fr) Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HU217551B (hu) 6[(2-Hidroxi-etil)-amino-alkil]-5,11-dioxo-5,6-dihidro-11H-indén[1,2-c]izokinolin-származékok, valamint eljárás előállításukra, továbbá hatóanyagként e vegyületeket tartalmazó gyógyászati készítmények
FR2845996A1 (fr) Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP0760375B1 (de) Antitumor-indolopyrolocarbazolderivat
US4576945A (en) Hexaalkylmelamine-amino-oxy compounds
US5100881A (en) N-(23-vincristinoyl) and n-(5'-noranhydro-23-vinblastinoyl) compounds of 1-aminomethylphosphonic acid useful for the treatment of neoplastic diseases
EP0601520A1 (de) Trifluorothymidinderivate, Verfahren zu ihrer Herstellung und Antikrebsmittel, die Sie enthalten
EP0456514B1 (de) 2-Fluorneplanocin A und seine Herstellung
US5218126A (en) Halogen substituted mitomycin derivatives
JPH0834788A (ja) ピロロベンゾカルバゾール誘導体及びその製造方法
GB2287463A (en) Bis-anthracycline derivatives
HU188152B (en) Process for the preparation of anticancer n-phthalidyl-5-fluoro-uracile derivatives
HK1000707A (en) Dc-88a derivatives
JPH092951A (ja) 抗腫瘍剤及びニドルフィン誘導体
JPH0834786A (ja) トリフルオロメチルピロロインドール誘導体及びその製造方法

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20061117